BSE filing, BSE: 540310. Summary written from the filing by ALFA Finder's alert engine.
Classic Filaments Ltd: key numbers
- Share price
- ₹97.00
- Market cap
- ₹59.30 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.15 Cr
- P/E (TTM)
- -671.6×Sector 49.5×
- Promoter holding
- 47.56%-20.95% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Classic Filaments Ltd
All →Classic Filaments Annual General Meeting
Classic Filaments Limited conducted its 36th Annual General Meeting on September 28, 2026, where shareholders considered financial statements and special business.
Classic Filaments Capital Structure Change
Classic Filaments received BSE approval to list 26,94,316 preferential-issue shares at Rs. 51.50, raising ₹1.39 Crore. Trading commenced on 24 September 2026.
- Value
- ₹13.88 Cr
Classic Filaments Other Announcement
Classic Filaments Limited has appointed Mr. Narendra Singh Negi as Internal Auditor for a 12-month term, effective from September 5, 2026.
- Execution
- 12 months
Classic Filaments Annual General Meeting
Classic Filaments Limited has scheduled its 36th Annual General Meeting on September 28, 2026. The meeting will be held via video conferencing.
Classic Filaments Acquisition Worth ₹12 Cr
Classic Filaments Limited completed the acquisition of a 51% stake in Procasts Engineering Private Limited for Rs. 12.00 Crore. The board also approved an internal auditor appointment.
- Value
- ₹12.00 Cr
Classic Filaments Other Announcement
Classic Filaments Ltd filed its quarterly shareholding pattern. The filing discloses promoter and public shareholding data as per regulatory compliance requirements.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.